The rituximab biosimilars market has been rapidly evolving, driven by a multitude of factors that have created a fertile ground for growth and innovation. In 2023, the market size was valued at USD 2.37 billion and is projected to grow at an impressive compound annual growth rate (CAGR) of 15.7% during the forecast period of 2024-2032, reaching a value of USD 8.81 billion by 2032....